A Mendelian randomisation, propensity score matching study to investigate causal association between serum homocysteine and intracranial aneurysm
Open Access
- 28 July 2023
- journal article
- research article
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 9 (3) , 202-211
Abstract
Background and purpose Recent observational studies have reported that serum total homocysteine (tHcy) is associated with intracranial aneurysms (IAs). However, the causal effect of tHcy on IAs is unknown. We leveraged large-scale genetic association and real-world data to investigate the causal effect of tHcy on IA formation. Methods We performed a two-sample Mendelian randomisation (MR) using publicly available genome-wide association studies summary statistics to investigate the causal relationship between tHcy and IAs, following the recommendations of the Strengthening the Reporting of Observational Studies in Epidemiology-MR statement. Furthermore, a propensity score matching (PSM) analysis was conducted to evaluate the detailed effects of tHcy on risk of IA formation by utilizing real-world multicentre data, including 9902 patients with and without IAs (1:1 matched). Further interaction and subgroup analyses were performed to elucidate how tHcy affects risk of IA formation. Results MR analyses indicated that genetically determined tHcy was causally associated with IA risk (OR, 1.38, 95% CI 1.07 to 1.79; p=0.018). This is consistent with the more conservative weighted median analysis (OR, 1.41, 95% CI 1.03 to 1.93; p=0.039). Further sensitivity analyses showed no evidence of horizontal pleiotropy or heterogeneity of single nucleotide polymorphisms in causal inference. According to the PSM study, we found that, compared with low tHcy (≤15 µmol/L), moderate tHcy (>15–30 µmol/L) (OR 2.13, 95% CI 1.93 to 2.36) and high tHcy (>30 µmol/L) (OR 3.66, 95% CI 2.71 to 4.95) were associated with a higher IA risk (p trend Conclusion Both large-scale genetic evidence and multicentre real-world data support a causal association between tHcy and risk of IA formation. Serum tHcy may serve as a biomarker to identify high-risk individuals who would particularly benefit from folate supplementation.Keywords
Funding Information
- Xin Feng (82201427)
- Duan, Chuanzhi (2016YFC1300800)
This publication has 34 references indexed in Scilit:
- Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery diseaseThe American Journal of Clinical Nutrition, 2013
- Recoding preventive exposures to get valid measures of interaction on an additive scaleEuropean Journal of Epidemiology, 2011
- Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trialsEuropean Heart Journal, 2008
- Primary Prevention of Ischemic StrokeStroke, 2006
- Homocysteine Lowering with Folic Acid and B Vitamins in Vascular DiseaseNew England Journal of Medicine, 2006
- Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002Circulation, 2006
- Remodeling of Saccular Cerebral Artery Aneurysm Wall Is Associated With RuptureStroke, 2004
- Facts and Recommendations about Total Homocysteine Determinations: An Expert OpinionClinical Chemistry, 2004
- Lifestyle, Homocysteine, and the Metabolic SyndromeMetabolic Syndrome and Related Disorders, 2003
- Total Homocyst(e)ine Concentration and the Likelihood of Nonfatal StrokeStroke, 1998